论文部分内容阅读
采用阿托品、654-2治疗肺咯血24例中,男16例,女8例;年龄27～68岁;其中肺结核22例(浸润型18例,慢纤洞型4例),支气管扩张2例;少量咯血8例,中等量9例,大量7例。治疗方法:在综合治疗基础上,当咯血时使用阿托品1mg 或654-2 10mg,进行两侧“内关”穴位注射;肌肉或皮下注射。疗效:穴位注射组11例28次,显效(立即止血)18次,好转(咯血量减少)6次,无效4次。肌肉或皮下注射
Atropine, 654-2 in the treatment of pulmonary hemoptysis in 24 cases, 16 males and 8 females; aged 27 to 68 years; of which 22 cases of pulmonary tuberculosis (infiltration 18 cases, 4 cases of slow-sighted hole), bronchiectasis in 2 cases; A small amount of hemoptysis in 8 cases, a moderate amount of 9 cases, a large number of 7 cases. Treatment: On the basis of comprehensive treatment, when hemoptysis use atropine 1mg or 654-2 10mg, on both sides of the “internal customs” point injection; muscle or subcutaneous injection. Efficacy: point injection group of 11 cases 28 times, markedly (immediately stop bleeding) 18 times, improved (hemoptysis volume decreased) 6 times, invalid 4 times. Muscle or subcutaneous injection